THERALINK TECHNOLOGIES, INC. : Change in Directors or Principal Officers (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers

On December 31, 2021, the board of directors (the "Board") of Theralink Technologies, Inc. (the "Company") approved an increase in the base salary of Thomas E. Chilcott, III, the Company's Chief Financial Officer, from $225,000 to $300,000 per year. The increase is effective January 1, 2022. The Board also approved two new bonuses for which Mr. Chilcott will be eligible: (i) a $37,500 bonus payable upon the Company's completion of a capital raise of at least $1,000,000; and (ii) a $37,500 bonus payable upon the Company's completion of a capital raise of at least $2,000,000 in the aggregate.

© Edgar Online, source Glimpses